Partners Value Investments L.P. Announces 2018 Annual

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
37
Partners Value Investments L.P. Announces 2018 Annual Results

TORONTO, April 01, 2019 (GLOBE NEWSWIRE) -- Partners Value Investments L.P. (the “Partnership”, TSX: PVF.UN TSX:PVF.PR.U) announced today its financial results for the year ended December 31, 2018. All amounts are stated in US dollars.

The Partnership generated net income of $125 million for the year ended December 31, 2018 compared to $81 million in the prior year. The increase in net income was primarily driven by foreign currency gains, partially offset by lower recognized valuation gains.

The market price of a Brookfield share was $38.35 as at December 31, 2018 (2017 – $43.54).

Consolidated Statements of Operations

For the years ended December 31 (Thousands, US dollars)      
              2018       2017  
Investment income                      
Dividends             $ 73,462     $ 87,666  
Other investment income               6,636        2,142  
                80,098        89,808  
Expenses                      
Operating expenses               (2,134 )      (13,418 )
Financing costs               (2,945 )      (5,358 )
Retractable preferred share dividends               (26,854 )      (27,341 )
                (31,933 )      (46,118 )
                48,165       43,690  
Other items                      
Investment valuation gains               4,985       87,784  
Amortization of deferred financing costs               (2,360 )      (2,473 )
Current taxes               (12,816 )      (14,745 )
Deferred taxes               5,957       (5,314 )
Equity accounted income               (18 )     253  
Foreign currency gains (losses)               81,384        (29,112 )
Net income             $   125,297     $ 80,083  
                           

Financial Profile and Net Book Value

The Partnership’s principal investment is its interest in 86 million Class A Limited Voting Shares (“Brookfield shares”) of Brookfield Asset Management Inc. (“Brookfield”), representing a 9% fully-diluted interest as at December 31, 2018. The information in the following table shows the changes in net book value:

         
For the years ended December 31 (Thousands, except per unit amounts) 2018     2017
  Total       Per Unit       Total       Per Unit
Net book value, beginning of period 1 $ 3,268,176     $ 37.05     $ 2,337,457     $ 26.49
Net income 2   102,804       1.17       57,790       0.65
Other comprehensive income 2   (494,704 )     (5.61 )     848,407       9.61
Adjustment for impact of warrant 3   (29,688 )     (0.34 )     24,533       0.28
Equity LP repurchase   (2,350 )     (0.03 )     (11 )    
Net book value, end of period 1,4,5 $ 2,844,238     $ 32.24     $ 3,268,176     $ 37.03
  1. Calculated on a fully diluted basis, net book value is non-IFRS measure.
  2. Attributable to Equity Limited Partners.
  3. The basic weighted average number of Equity Limited Partnership (“Equity LP”) units outstanding during the year ended December 31, 2018 was 73,524,856. The diluted weighted average number of Equity Limited Partnership (“Equity LP”) units available and outstanding during the year ended December 31, 2018 was 88,233,622; this includes the 14,708,766 Equity LP units issued through the exercise of all outstanding warrants.
  4. At the end of the year, the diluted Equity LP units outstanding were 88,200,297 (December 31, 2017 – 88,249,897).
  5. Net book value is a non-IFRS measure and is equal to total equity less General Partner equity and Preferred Limited Partners’ equity, plus the value of consideration to be received on exercising of warrants, which as at December 31, 2017 was $237 million (December 31, 2017 – $380 million).

Financial Profile

The Company’s principal investment is its interest in 86 million Class A Limited Voting Shares (“Brookfield shares”) of Brookfield, representing a 9% fully diluted interest as at December 31, 2018. In addition, the Company owns a diversified investment portfolio of marketable securities.

The information in the following table has been extracted from the Company’s Statement of Financial Position:

Statement of Financial Position

           
As at (Thousands, US dollars, except per share amounts)   December 31, 2018     December 31, 2017
Assets          
Cash and cash equivalents $ 272,322   $ 29,801
Investment in Brookfield Asset Management Inc. 1   3,291,927     3,737,431
Other investments carried at fair value   442,505     750,467
Accounts receivable and other assets   20,685     6,443
Equity accounted investment 2,5       16,745
  $ 4,027,439   $ 4,540,887
Liabilities and Equity          
Accounts payable and other liabilities $ 30,767   $ 108,744
Preferred shares 4   602,724     575,620
Deferred taxes 5   395,015     468,040
    1,028,506     1,152,404
Equity          
Common equity   2,998,933     3,388,483
  $ 4,027,439   $ 4,540,887
           
  1. The investment in Brookfield Asset Management Inc. consists of 86 million Brookfield shares with a quoted market value of $38.35 per share as at December 31, 2018 (December 31, 2017 – $43.54).
  2. Certain reclassifications have been made to the comparative figures reported. These reclassifications had no effect on the reported results of operations. A reclassification has been made to the Statement of Financial Position for the year ended December 31, 2017 to reclassify the amount previously disclosed as goodwill of $3,102 to equity accounted investment (EAI).
  3. Represents $613 million of retractable preferred shares less $10 million of unamortized issue costs as at December 31, 2018 (December 31, 2017 – $585 million less $9 million).
  4. The deferred tax liability represents the potential future income tax liability of the Partnership recorded for accounting purposes based on the difference between the carrying values of the Partnership’s assets and liabilities and their respective tax values, as well as giving effect to estimated capital and non-capital losses.
  5. Effective April 1, 2018, the basis of accounting for Trisura was changed from EAI to FVTOCI.

For further information, contact Investor Relations at ir@pvii.ca or 416-956-5142.

Note: This news release contains “forward-looking information” within the meaning of Canadian provincial securities laws and “forward-looking statements” within the meaning of applicable Canadian securities regulations. The words “potential” and “estimated” and other expressions which are predictions of or indicate future events, trends or prospects and which do not relate to historical matters, identify forward-looking information. Forward-looking information in this news release includes statements with regard to the Company’s potential future income taxes.

Although the Company believes that its anticipated future results, performance or achievements expressed or implied by the forward-looking statements and information are based upon reasonable assumptions and expectations, the reader should not place undue reliance on forward-looking statements and information because they involve known and unknown risks, uncertainties and other factors, many of which are beyond its control, which may cause the actual results, performance or achievements of the Company to differ materially from anticipated future results, performance or achievement expressed or implied by such forward-looking statements and information.

Factors that could cause actual results to differ materially from those contemplated or implied by forward-looking statements and information include, but are not limited to: the financial performance of Brookfield Asset Management Inc., the impact or unanticipated impact of general economic, political and market factors; the behavior of financial markets, including fluctuations in interest and foreign exchanges rates; global equity and capital markets and the availability of equity and debt financing and refinancing within these markets; strategic actions including dispositions; changes in accounting policies and methods used to report financial condition (including uncertainties associated with critical accounting assumptions and estimates); the effect of applying future accounting changes; business competition; operational and reputational risks; technological change; changes in government regulation and legislation; changes in tax laws, catastrophic events, such as earthquakes and hurricanes; the possible impact of international conflicts and other developments including terrorist acts; and other risks and factors detailed from time to time in the Company’s documents filed with the securities regulators in Canada.

The Company cautions that the foregoing list of important factors that may affect future results is not exhaustive. When relying on the Company’s forward-looking statements and information, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Except as required by law, the Company undertakes no obligation to publicly update or revise any forward-looking statements and information, whether written or oral, that may be as a result of new information, future events or otherwise.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 3

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 4

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights Into December's Top Mobile and CTV Apps for Revenue

Updated Category News Views 170

Top Revenue Generating Mobile and CTV Apps for December 2024 The evolving landscape of mobile and Connected TV (CTV) applications continually captivates users and advertisers alike. As 2024 comes to a close, the spotlight shines on the highest-grossing apps in North America, specifically in the United States and Canada, revealing significant trends in user engagement and...

Continue Reading
LET Mining's Cloud Strategy for XRP: Earn Passive Income Today

Updated Category News Views 106

Introduction to LET Mining's New Approach LET Mining is making waves with its innovative strategy that leverages XRP for cloud mining. This fresh perspective has caught the attention of numerous XRP holders, sparking excitement about its long-term profit potential. As more users join the platform, LET Mining is focusing on refining its computing power allocation to...

Continue Reading
Understanding Recent Changes in American Intl Gr's Short Interest

Updated Category News Views 70

Understanding American Intl Gr's Short Interest Dynamics American Intl Gr (AIG) has recently seen a notable change in its short percent of float, which has decreased by 3.24% since the last report. This change reflects a current total of 10.23 million shares sold short, making up approximately 1.79% of all available shares for trading. With the current trading volume,...

Continue Reading
Exploring the Future of the Phosphate Market: Growth and Trends

Updated Category News Views 520

The Rising Phosphate Market: An Overview The phosphate market is experiencing remarkable growth, projected to soar to approximately $219.74 billion in the coming years, driven by an annual growth rate of 3.9%. This growth is closely linked to the rising global demand for agricultural fertilizers, which play a crucial role in providing essential nutrients for plants....

Continue Reading
Clene Inc. to Engage with Investors at Benchmark Conference

Updated Category News Views 108

Clene Inc. to Engage with Investors at Benchmark Conference Clene Inc. (Nasdaq: CLNN), a dynamic clinical-stage biopharmaceutical company, is making its mark in the healthcare industry by focusing on innovative solutions for neurodegenerative diseases. Their mission is clear: to enhance mitochondrial health and safeguard neuronal functions. With a commitment to tackling...

Continue Reading